Cite
HARVARD Citation
Staniszewska, A. et al. (2022). PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors. Oncoimmunology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Staniszewska, A. et al. (2022). PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors. Oncoimmunology. p. . [Online].